343
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Women with PCOS with a History of Early Pregnancy Loss Show a Higher Risk of Gestational Diabetes Mellitus

, , , & ORCID Icon
Pages 6409-6416 | Published online: 05 Oct 2021

References

  • Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41. doi:10.1186/1741-7015-8-41
  • Anagnostis P, Tarlatzis BC, Kauffman RP. Polycystic ovarian syndrome (PCOS): long-term metabolic consequences. Metabolism. 2018;86:33–43. doi:10.1016/j.metabol.2017.09.016
  • Zeng XL, Zhang YF, Tian Q, Xue Y, An RF. Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: a meta-analysis. Medicine. 2016;95(36):e4526. doi:10.1097/MD.0000000000004526
  • Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(2):524–529. doi:10.1210/jcem.87.2.8207
  • Gray RH, Wu LY. Subfertility and risk of spontaneous abortion. Am J Public Health. 2000;90(9):1452–1454.
  • Han AR, Kim HO, Cha SW, et al. Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control study. Clin Exp Reprod Med. 2011;38(2):103–108. doi:10.5653/cerm.2011.38.2.103
  • Wang JX, Davies MJ, Norman RJ. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod. 2001;16(12):2606–2609. doi:10.1093/humrep/16.12.2606
  • Hu L, Du J, Lv H, et al. Influencing factors of pregnancy loss and survival probability of clinical pregnancies conceived through assisted reproductive technology. Reprod Biol Endocrinol. 2018;16(1):74. doi:10.1186/s12958-018-0390-6
  • Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Håberg SE. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ. 2019;364:l869.
  • San Lazaro Campillo I, Meaney S, McNamara K, O’Donoghue K. Psychological and support interventions to reduce levels of stress, anxiety or depression on women’s subsequent pregnancy with a history of miscarriage: an empty systematic review. BMJ Open. 2017;7(9):e017802. doi:10.1136/bmjopen-2017-017802
  • Zhang LM, Yang YN, Zhang RX, et al. [Comparison of the etiological constitution of two and three or more recurrent miscarriage]. Zhonghua Fu Chan Ke Za Zhi. 2018;53(12):855–859. Chinese.
  • Cavalcante MB, Sarno M, Cavalcante C, Araujo Júnior E, Barini R. Coagulation biomarkers in women with recurrent miscarriage and polycystic ovarian syndrome: systematic review and meta-analysis. Geburtshilfe Frauenheilkd. 2019;79(7):697–704. doi:10.1055/a-0884-3212
  • Rotterdam ESHRE/ASRM‐Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–47. doi:10.1093/humrep/deh098
  • Li W, Chen Q, Xie Y, Hu J, Yang S, Lin M. Prevalence and degree of insulin resistance in Chinese Han women with PCOS: results from euglycemic-hyperinsulinemic clamps. Clin Endocrinol. 2019;90(1):138–144. doi:10.1111/cen.13860
  • Yatsenko SA, Rajkovic A. Genetics of human female infertility. Biol Reprod. 2019;101(3):549–566. doi:10.1093/biolre/ioz084
  • Chen C, Lu FC. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17:1–36.
  • Ghafurniyan H, Azarnia M, Nabiuni M, Karimzadeh L. The effect of green tea extract on reproductive improvement in estradiol valerate-induced polycystic ovarian syndrome in rat. Iran J Pharm Res. 2015;14(4):1215–1233.
  • Wang T, Fu H, Chen L, Xu Y. [Pregnancy complications among women with polycystic ovary syndrome in China: a meta-analysis]. Zhong Nan Da xue Xue Bao Yi Xue Ban = J Cent South Univ Med Sci. 2017;42(11):1300–1310. Chinese.
  • Hart R, Doherty DA. The potential implications of a PCOS diagnosis on a woman’s long-term health using data linkage. J Clin Endocrinol Metab. 2015;100(3):911–919. doi:10.1210/jc.2014-3886
  • Gilbert EW, Tay CT, Hiam DS, Teede HJ, Moran LJ. Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews. Clin Endocrinol. 2018;89(6):683–699. doi:10.1111/cen.13828
  • Doherty DA, Newnham JP, Bower C, Hart R. Implications of polycystic ovary syndrome for pregnancy and for the health of offspring. Obstet Gynecol. 2015;125(6):1397–1406. doi:10.1097/AOG.0000000000000852
  • Christ JP, Gunning MN, Meun C, et al. Pre-conception characteristics predict obstetrical and neonatal outcomes in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2019;104(3):809–818. doi:10.1210/jc.2018-01787
  • Mumm H, Jensen DM, Sørensen JA, et al. Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes. Acta Obstet Gynecol Scand. 2015;94(2):204–211. doi:10.1111/aogs.12545
  • Hart R. PCOS and infertility. Panminerva Med. 2008;50(4):305–314.
  • Azziz R. Polycystic ovary syndrome. Obstet Gynecol. 2018;132(2):321–336. doi:10.1097/AOG.0000000000002698
  • Jakubowicz D, Sharma ST. Insulin resistance and early pregnancy loss in polycystic ovary syndrome. In: Diumanti-Kandarakis E, Nestler JE, Panidis D, Pasquali R, editors. Contemporary Endocrinology: Insulin Resistance and Polycystic Ovarian Syndrome: Pathogenesis, Evaluation, and Treatment. Totowa, NJ: Humana Press Inc.; 2007:451–466.
  • Ghazeeri GS, Nassar AH, Younes Z, Awwad JT. Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview. Acta Obstet Gynecol Scand. 2012;91(6):658–678. doi:10.1111/j.1600-0412.2012.01385.x
  • Homburg R. Pregnancy complications in PCOS. Best Pract Res Clin Endocrinol Metab. 2006;20(2):281–292. doi:10.1016/j.beem.2006.03.009